GleamWall
中文EN

RDNT RadNet, Inc.

Services-Medical Laboratories · Nasdaq · SEC CIK 790526 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY21.1%
TTM net income YoY-76.1%
TTM EPS YoY-81.3%
Revenue 3-yr CAGR14.7%
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin3.1%
Net margin-0.9%
FCF margin—
EBITDA margin10.6%

Returns

ROE-2.1%
ROA-0.6%
ROIC (approx.)2.8%
Asset turnover0.60x

Leverage & solvency

Liabilities / assets66.4%
Debt / equity1.18x
Current ratio1.49x
Interest coverage0.99x

Cash quality & payout

Operating cash flow / net income-15.54x
Accruals ratio-9.3%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2026Q32026-09-302026Q22026-06-302026Q12026-03-312025Q4*2025-12-312025Q32025-09-302025Q22025-06-302025Q12025-03-312024Q4*2024-12-31
Income statement
Revenue$638.26M$622.72M$575.63M$547.71M$522.87M$498.23M$471.40M$477.10M
Operating income$30.26M$39.47M-$23.90M$27.82M$27.39M$30.88M-$24.10M$24.52M
Interest expense$20.68M$18.15M$17.66M$18.13M$17.36M$17.19M$17.24M$18.07M
Pretax income$27.51M$26.62M-$32.83M$20.92M$20.27M$23.85M-$33.13M$15.32M
Income tax$8.36M$6.36M-$8.10M$11.05M$6.38M$820,000-$3.40M$1.10M
Net income$4.15M$7.53M-$33.47M-$597,000$5.42M$14.45M-$37.93M$5.34M
EBITDA$77.27M$85.00M$21.06M$68.68M$67.19M$66.87M$11.38M$60.54M
EPS (basic)0.050.10-0.43—0.070.19-0.51—
EPS (diluted)0.050.10-0.43—0.070.19-0.51—
Weighted avg. shares (diluted)79.17M78.73M77.06M—77.39M75.53M74.38M—
Balance sheet
Cash & equivalents$750.61M$726.27M$455.34M$767.22M$804.72M$833.15M$717.32M$740.02M
Receivables$248.89M$241.84M$209.09M$200.32M$210.55M$199.99M$200.13M$185.82M
Current assets$1.07B$1.04B$740.77M$1.03B$1.08B$1.09B$1.02B$1.02B
PP&E, net$904.27M$879.90M$862.06M$807.70M$780.50M$741.38M$708.25M$694.79M
Goodwill$1.14B$1.12B$1.09B$907.66M$827.53M$751.51M$717.48M$710.66M
Intangibles$235.06M$245.35M$253.48M$148.51M$124.91M$91.08M$79.74M$81.35M
Total assets$4.28B$4.23B$3.89B$3.76B$3.67B$3.51B$3.34B$3.29B
Current liabilities$716.64M$697.82M$635.63M$586.76M$574.91M$546.21M$505.40M$479.71M
Short-term debt$31.80M$30.67M$26.51M$25.42M$25.45M$25.48M$24.68M$24.69M
Long-term debt$1.29B$1.30B$1.06B$1.06B$1.07B$1.08B$985.45M$991.57M
Total debt$1.33B$1.33B$1.09B$1.09B$1.10B$1.10B$1.01B$1.02B
Total liabilities$2.84B$2.83B$2.53B$2.40B$2.35B$2.34B$2.20B$2.15B
Shareholders' equity$1.12B$1.10B$1.08B$1.09B$1.06B$932.31M$898.14M$902.31M
Net debt$574.69M$606.26M$631.14M$322.70M$291.62M$269.58M$292.81M$276.25M
Shares outstanding78.77M78.65M78.55M77.40M77.03M75.07M74.96M74.04M
Cash flow statement
Operating cash flow$90.57M$94.10M$78.97M$84.16M$52.83M$120.35M$41.48M$42.53M
Investing cash flow-$53.09M-$63.55M-$370.97M-$113.94M-$75.72M-$97.45M-$56.75M-$48.81M
Financing cash flow-$12.84M$240.22M-$17.50M-$7.39M-$5.32M$92.43M-$7.51M-$2.12M
Depreciation & amortization$47.01M$45.53M$44.97M$40.85M$39.80M$35.99M$35.48M$36.02M
Stock-based compensation$10.02M$10.54M$31.38M$8.32M$9.04M$8.74M$28.49M$8.46M

Free plan shows the latest 8 periods; Pro shows all 66 🔒

· This company does not report gross profit in XBRL.

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.